相关实验视频

Updated: May 6, 2026

Mouse Model of Surgically-induced Endometriosis by Auto-transplantation of Uterine Tissue

Mouse Model of Surgically-induced Endometriosis by Auto-transplantation of Uterine Tissue

Published on: January 6, 2012

类衍生物在子宫内膜细胞中的活性-选择性

Kaio S Gomes¹, Julia A Coelho¹, Pedro E H Tesser²

¹Metal Biochemistry and Oxidative Stress Laboratory, Centre for Natural Sciences and Humanities, Federal University of ABC, Santo Andre, SP 09210-5800, Brazil.

|February 23, 2026

概括

带有电子吸收组的哈尔科因对子宫内膜异位症细胞具有选择性毒性,而其他黄类药物则具有细胞保护作用. 这项研究确定了针对子宫内膜异位症治疗的有希望的化合物.

科学领域:

药用化学医学化学
药理学药理学是指药理学的学科.
分子生物学分子生物学

背景情况:

自然的多基,特别是黄类,具有多样化的生物活性.
子宫内膜异位症是一种以子宫外的子宫内膜状组织存在为特征的疾病.

研究的目的:

在eutopic子宫内膜和子宫内膜异位症模型中评估flavonoid衍生物的细胞毒性.
阐明选择性细胞毒性对子宫内膜异位症细胞的结构-活性关系.

主要方法:

37种黄类衍生物 (化合物1-37) 的合成和选.
细胞毒性测定使用石川 (优托普性子宫内膜) 和12Z (子宫内膜症) 表皮细胞系.
物理化学性质 (脂性,TPSA,结) 与细胞毒性的相关性分析.

主要成果:

高极性和TPSA的黄类药物显示出较低的细胞毒性和细胞保护作用.
具有取电子替代物和高脂性 (log P > 3.5) 的哈尔孔对12Z细胞具有选择性毒性.
化合物24和28对12Z细胞表现出显著的选择性细胞毒性,降低了约50%的活力,同时保持了石川细胞的活力.

结论:

含有特定替代物的形体代表了开发选择性子宫内膜异位症治疗的有希望的支架.
物理化学性质,包括脂性和TPSA,是生物活动的关键决定因素.
这项研究为设计针对子宫内膜异位症的新型化合物提供了基础,对健康的子宫内膜细胞的影响最小.

更多相关视频

Isolation of Human Endometrial Stromal Cells for In Vitro Decidualization

Isolation of Human Endometrial Stromal Cells for In Vitro Decidualization

Published on: September 1, 2018

Noninvasive Monitoring of Lesion Size in a Heterologous Mouse Model of Endometriosis

Noninvasive Monitoring of Lesion Size in a Heterologous Mouse Model of Endometriosis

Published on: February 26, 2019

相关概念视频

Selectins

Selectins

Cell adhesion is an essential aspect of multicellularity. While stable cell interactions usually occur between cells of the same type, transient cell interactions occur between cells of different tissue types, such as between neutrophils and endothelial cells. Selectins are one class of cell adhesion molecules (CAMs) that bind carbohydrate ligands to form transient cell adhesion. They are rod-like proteins with a long extracellular part of variable length ending with the lectin domain,...

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...